CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 06:00:02 21/08/26 am AEST			5-day change	1st Jan Change
291.45 ^USD	+0.50%		+3.62%	+46.10%

21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
20/08	Charles River, Medigen Partner on Multivalent Enterovirus Vaccine	MT

Insiders

21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
14/08	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
07/08	Charles River Laboratories International Insider Sold Shares Worth $1,327,098, According to a Recent SEC Filing	MT
02/07	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
12/05	Charles River Laboratories International, Inc. Announces Board Elections	CI
19/02	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
18/02	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
18/02	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
13/01	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
13/01	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
09/01	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
09/01	Charles River Laboratories International, Inc. Announces Changes in Board	CI
09/01	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
09/01	Charles River Laboratories announces planned retirement of James C. Foster	RE
16/10/25	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
16/09/25	Charles River Laboratories announces chief financial officer transition	RE
16/09/25	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
16/09/25	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
16/09/25	Charles River Laboratories Says CFO to Step Down	MT
07/05/25	Charles River to add new directors, review business in agreement with Elliott	RE
07/05/25	Charles River Laboratories International, Inc. Announces Board Changes	CI
13/11/24	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
13/08/24	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
05/03/24	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
02/03/24	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT